Literature DB >> 517884

Potassium iodide sensitivity in four patients with hypocomplementemic vasculitis.

J G Curd, H Milgrom, D D Stevenson, D A Mathison, J H Vaughan.   

Abstract

During metabolism studies of radiolabeled proteins in 126 participants four patients were suspected of being sensitive to potassium iodide (Kl) because they repeatedly developed urticaria and other symptoms after Kl administration. Two of the four patients suspected of Kl sensitivity and 10 control patients were orally challenged with Kl to document and characterize Kl sensitivity and to evaluate the possible association(s) of Kl sensitivity with urticaria, hypocomplementemia, and vasculitis. The Kl challenges in the two sensitive patients precipitated urticaria, angioedema, polymyalgias, conjunctivitis, and coryza. One of these two patients also developed a severe systemic illness characterized by fever, headache, peritonitis, episcleritis, and pneumonitis. The four sensitive patients were strikingly similar in that they exhibited hypocomplementemia and dermal vasculitis associated with chronic urticaria or systemic lupus erythematosus, suggesting that other patients with similar clinical features may be sensitive to Kl and that Kl may precipitate severe systemic illness in them.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 517884     DOI: 10.7326/0003-4819-91-6-853

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  6 in total

1.  MacDuffie syndrome and primary sclerosing cholangitis: an exceptional association.

Authors:  Xavier Roblin; Jean-Marc Phelip; Marie Noelle Hilleret; Nathalie Sturm; Frederic Heluwaert; Bruno Bonaz; Jean-Pierre Zarski
Journal:  Dig Dis Sci       Date:  2006-06       Impact factor: 3.199

2.  Allergy-epitomes of progress: urticarial vasculitis.

Authors:  J G Curd; W Lumry; D D Stevenson; D A Mathison
Journal:  West J Med       Date:  1982-08

Review 3.  Lupus diseases associated with hereditary and acquired deficiencies of complement.

Authors:  V Agnello
Journal:  Springer Semin Immunopathol       Date:  1986

4.  Recommendations on the use of potassium iodide as a thyroid-blocking agent in radiation accidents: an FDA update.

Authors:  B Shleien; J A Halperin; J M Bilstad; P Botstein; E V Dutra
Journal:  Bull N Y Acad Med       Date:  1983-12

5.  Indications for using potassium iodide to protect the thyroid from low level internal irradiation.

Authors:  J Robbins
Journal:  Bull N Y Acad Med       Date:  1983-12

6.  Risks in mass distribution of potassium iodide.

Authors:  R S Yalow
Journal:  Bull N Y Acad Med       Date:  1983-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.